In today’s stock market trade, a slew of stocks will be on investors’ radar, including Tata Power, Life Insurance Corporation ...
Updated data show AYVAKIT® (avapritinib) was safe and effective for long-term treatment of ISM, with sustained symptom and quality-of-life bene ...
Cash Burn of $5.2 million in Q4 remains in line with projected $4-5 million quarterly rangeCash and investments on hand are sufficient to fund ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results